Dr. Judy Walker, PhD

Chief Medical Officer at Arthex Biotech

Speaker

Dr. Walker started her career as a clinical neurologist and clinical trial investigator in Canada. In the late 1990s, Dr. Walker joined industry and has spent the last 25 years plus in a variety of clinical and medical leadership roles in the US, Switzerland, UK and Singapore. Her focus throughout this time has been to bring effective and safe drugs to market for patients with some of the most disabling neurological conditions, including many rare diseases. At Arthex, Dr. Walker is responsible for all clinical, medical and regulatory activities in the company, moving Arthex’ lead investigational compound, an anti-miR23b oligonucleotide known as ATX-01, into clinical studies for Myotonic Dystrophy, preparing for ongoing development of the Arthex RNA therapeutics pipeline, and building a highly skilled team to ensure success.